Market News AIOpen the app

UNCY stock news · Unicycive Therapeutics, Inc.

Stories about Unicycive Therapeutics, Inc. (UNCY) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for UNCY

Follow Unicycive Therapeutics, Inc. (UNCY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for UNCY
Free on the App Store and Google Play, or on the web.
  1. Nov 16, 2026, 9:29 AM ET · Trial

    Unicycive Therapeutics shared its third quarter results and said the FDA accepted its drug application.

    Good for UNCY

    The FDA accepted Unicycive’s OLC application, set a March 25, 2027 decision date, and the company reported $59 million in cash and investments. This favors UNCY, though approval remains uncertain.